Berman Capital Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$9K Hold
177
﹤0.01% 1224
2021
Q2
$10K Hold
177
﹤0.01% 1136
2021
Q1
$8K Hold
177
﹤0.01% 1109
2020
Q4
$7K Hold
177
﹤0.01% 1049
2020
Q3
$5K Hold
177
﹤0.01% 1045
2020
Q2
$4K Buy
+177
New +$4.63K ﹤0.01% 1066

Other funds holding LMAT

Berman Capital Advisors's LMAT Position: Q3 2021 in Review

Berman Capital Advisors held its LeMaitre Vascular (LMAT) position steady in Q3 2021 at 177 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1224.

Berman Capital Advisors first reported a position in LMAT in Q2 2020 and has held it in 6 quarters since. The position peaked at $10K in Q2 2021. 195 funds tracked by Wall St. Rank hold LMAT as of Q3 2021.

  • Berman Capital Advisors held 177 shares of LeMaitre Vascular worth $9K as of Q3 2021.
  • Berman Capital Advisors left its LeMaitre Vascular share count unchanged in Q3 2021.
  • LeMaitre Vascular made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1224 holding.
  • Berman Capital Advisors first reported a position in LeMaitre Vascular in Q2 2020 and has held it in 6 quarters since.
  • Berman Capital Advisors's LeMaitre Vascular position peaked at $10K in Q2 2021.
  • 195 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.